Zymeworks (ZYME) Capital Expenditures (2021 - 2026)

Zymeworks has reported Capital Expenditures for 6 years, with the latest figure at $100000.0 in Q1 2026.

• Quarterly Capital Expenditures rose 525.0% year-over-year to $100000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.6 million (down 20.03% YoY) and the FY2025 annual result came in at $1.5 million, down 23.61% from the prior year.
• Capital Expenditures slipped to $100000.0 in Q1 2026 per ZYME's latest filing, from $581000.0 in the prior quarter.
• Over five years, Capital Expenditures peaked at $4.2 million in Q1 2022 and troughed at -$5.4 million in Q3 2022.
• A 5-year average of $293187.5 and a median of $462000.0 in 2025 frame the typical range for Capital Expenditures.
• The sharpest annual moves came in 2023 and 2026: Capital Expenditures tumbled 321.1% in 2023, then soared 525.0% in 2026.
• Over 5 years, Capital Expenditures stood at -$474000.0 in 2022, then sank by 321.1% to -$2.0 million in 2023, then jumped by 115.73% to $314000.0 in 2024, then surged by 85.03% to $581000.0 in 2025, then slumped by 82.79% to $100000.0 in 2026.
• According to Business Quant data, Capital Expenditures over the past three periods registered $100000.0, $581000.0, and $410000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.